Scarica l'app Stockscreener
83.89
4.59%
3.68
Dopo l'orario di chiusura:
83.48
-0.41
-0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$80.21
Aprire:
$81
Volume 24 ore:
771.20K
Relative Volume:
0.59
Capitalizzazione di mercato:
$2.90B
Reddito:
$635.89M
Utile/perdita netta:
$171.92M
Rapporto P/E:
19.25
EPS:
4.357
Flusso di cassa netto:
$151.36M
1 W Prestazione:
+9.65%
1M Prestazione:
+17.96%
6M Prestazione:
-37.89%
1 anno Prestazione:
-27.71%
Intervallo 1D:
$79.51
$83.98
Intervallo di 1 settimana:
$68.00
$83.98
Portata 52W:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
83.89 | 2.57B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
107.81 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.03 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
87.16 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.31 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.72 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
TransMedics Group (NASDAQ:TMDX) Coverage Initiated by Analysts at UBS Group - MarketBeat
UBS Initiates TransMedics Group at Neutral With $80 Price Target - Moomoo
TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum - ChartMill
Transmedics Group Inc (TMDX) Cash Flow - TradingKey
Transmedics Group Inc (TMDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Transmedics Group Inc (TMDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Transmedics Group Inc (TMDX) Income Statement - TradingKey
Transmedics Group Inc (TMDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TMDX|Transmedics Group Inc|Price:74.300|Chg%:+2.040 - TradingKey
Transmedics Group Inc (TMDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Transmedics Group Inc (TMDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Transmedics Group Inc (TMDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transmedics Group Inc (TMDX) Institutional Confidence - TradingKey
What Drove TransMedics' Stellar Q4 2025 Performance - Kavout | AI
Transmedics Group Inc (TMDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Investigation launched into TransMedics officers for possible breach of shareholder duties - Pluang
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
TMDX|Transmedics Group Inc|Price:73.000|Chg%:+0.740 - TradingKey
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), TransMedics Group (TMDX) and Hims & Hers Health (HIMS) - The Globe and Mail
TMDX: Transmedics Group Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Militia Capital Management LLC Acquires New Shares in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (TMDX) Projected to Post Earnings on Thursday - MarketBeat
Piper Sandler reiterates TransMedics stock rating on kidney opportunity By Investing.com - Investing.com Australia
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Danaher (DHR) and TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group Inc (TMDX) Shares Fall 4.2% -- What GF Score o - GuruFocus
TransMedics Group Inc (TMDX) Shares Fall 4.2% -- What GF Score of 69 Tells Investors - GuruFocus
TransMedics Sheds Some Claims In Organ Transfer Biz Suit - Law360
TMDX5812024 Bond Coupon Profile — Rate & Payments - TradingView
US89377MAB5 Bond Coupon Profile — Rate & Payments - TradingView
TransMedics Investors Partially Advance Organ Delivery Suit (1) - Bloomberg Law News
US89377MAB5 Bond Risk Profile - TradingView
TMDX5812024 Bond Profile — Key Metrics - TradingView
Fifth Third Bancorp Has $2.07 Million Position in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
TransMedics to report Q2 2026 financial results on August 4 - scanx.trade
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 - marketscreener.com
TransMedics will webcast its second-quarter results call Aug. 4 - Stock Titan
(TMDX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Principal Financial Group Inc. Has $23.01 Million Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Geneos Wealth Management Inc. Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200 - GlobeNewswire Inc.
TransMedics Group Inc (TMDX) Stock Price Quote Today & Current Price Chart | Capital.com EU - Capital.com
Regency Capital Management Inc. DE Purchases Shares of 21,846 TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (TMDX) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr
TransMedics Group (TMDX) awards RSUs and stock options to officer - Stock Titan
Form 4 TransMedics Group Inc For: 14 July By Investing.com - Investing.com India
TransMedics Group (TMDX) CEO receives major RSU and stock option grants - Stock Titan
TransMedics Group Jumps 6.7% Amid Sector-Wide Rally - AlphaStreet
TransMedics (TMDX) Sees 8% Surge, Trading at $76.90 - GuruFocus
TransMedics Group (NASDAQ:TMDX) Shares Up 6.3%Time to Buy? - MarketBeat
TransMedics Group, Inc. (TMDX): A Medical Device Innovator With A 63% Potential Upside - DirectorsTalk Interviews
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
0.67%
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):